Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

Update on Acquisition of Brands and Related Assets from Sanzyme Private Limited
01-02-2022

Earnings Call for Q3FY22 of J B Chemicals & Pharmaceuticals

Conference Call with J B Chemicals & Pharmaceuticals Ltd. Management and Analysts on new acquisitions. Listen to the full transcript.
28-01-2022
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Investor Presentation -in relation to the Acquisition of Brands and Related Assets from Sanzyme Private Limited.
27-01-2022
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

The Company has scheduled a conference call for investors and analysts on Thursday, January 27, 2022 at 3.30 p.m. IST to discuss the Acquisition of Brands and Related Assets from Sanzyme Private Limited.
26-01-2022
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Acquisition

Acquisition of a portfolio of brands, for use and commercialization within India, from Sanzyme Private Limited
26-01-2022
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Shareholding for the Period Ended December 31, 2021

JB Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
14-01-2022
Next Page
Close

Let's Open Free Demat Account